checkAd
    0,2160
     
    EUR
    +3,85 %
    +0,0080 EUR
    Letzter Kurs 08.05.24 Tradegate
    0,2040
     
    EUR
    14.718 STK
    Geldkurs 08:16:07
    0,2260
     
    EUR
    13.182 STK
    Briefkurs 08:16:07
    ISIN: AU000000PGC4 · WKN: A0Q4D2 · SYM: PXS · Australien

    Paragon Care Bilanz & GuV

    GuV in Mio AUD

    20192020202120222023e
    Umsatz236,09231,69235,84237,62307,63
    Bruttoergebnis vom Umsatz95,1078,7633,4136,5851,68
    EBITDA28,1612,1420,1829,2536,70
    EBIT18,154,0813,9821,3226,41
    Ergebnis vor Steuer12,19-77,2012,339,9120,85
    Ergebnis nach Steuern8,77-77,278,286,6310,76

    Bilanz in Mio AUD

    20192020202120222023e
    Aktiva384,20292,17291,92438,44448,52
    Umlaufvermögen137,93106,31113,21150,84132,65
    Summe Anlagevermögen246,27185,87178,71287,60315,87
    Passiva384,20292,17291,92438,44448,52
    Summe kurzfristige Verbindlichkeiten72,8784,8882,2189,0093,55
    Summe langfristige Verbindlichkeiten119,0195,0188,19107,31103,01
    Summe Fremdkapital191,88179,89170,40196,31196,56
    Bilanzielles Eigenkapital192,32112,28121,52235,82242,85

    Cashflow in AUD

    20192020202120222023e
    Cashflow1,16 Mio.5,29 Mio.27,46 Mio.19,03 Mio.17,75 Mio.

    Dividende

    2023e
    0,01Dividende je Aktie
    Kennzahlen und Daten von

    Dividendenrechner

    Dividendentermine der Branche

    DatumUnternehmenTermin
    10.05.2024
    Dividendentermin
    10.05.2024
    Dividendentermin
    13.05.2024
    Dividendentermin
    13.05.2024
    Dividendentermin
    14.05.2024
    Dividendentermin
    14.05.2024
    Dividendentermin
    15.05.2024
    Dividendentermin
    16.05.2024
    Dividendentermin

    Paragon Care Unternehmensprofil

    Paragon Care Insidertrades 2024

    Kennzahlen in AUD

    2023e20192020202120222023e2024e
    3,81 %Dividendenrendite-----
    10,50Kurs-Gewinn-Verhältnis (KGV)13,33-0,5712,2125,52-29,30
    7Kurs-Cash-Flow-Verhältnis (KCV)99,958,503,058,51-
    0,58Kurs-Buchwert-Verhältnis (KBV)0,670,400,720,73-
    0,47Kurs-Umsatz-Verhältnis (KUV)0,540,190,360,71-
    0,45Umsatz je Aktie0,740,890,670,36-
    0,03Cashflow je Aktie0,000,020,080,03-
    Umsatzrentabilität3,72 %-3,51 %2,79 %3,50 %
    Eigenkapitalrendite4,56 %-6,81 %2,81 %4,43 %
    Anlageintensität64,00 %64,00 %61,00 %66,00 %70,00 %
    Arbeitsintensität36,00 %36,00 %39,00 %34,00 %30,00 %
    Gesamtrendite2,28 %-2,84 %1,51 %2,40 %
    Eigenkapitalquote50,06 %38,43 %41,63 %53,79 %54,14 %
    Fremdkapitalquote49,94 %61,57 %58,37 %44,78 %43,82 %
    Verschuldungsgrad99,77 %160,21 %140,23 %83,25 %80,94 %
    Working Capital in Mio.65,0621,4331,0063,4639,10
    Deckungsgrad A78,09 %60,41 %68,00 %82,00 %76,88 %
    Deckungsgrad B113,96 %104,47 %112,99 %107,52 %98,28 %
    Deckungsgrad C94,28 %83,51 %87,68 %91,20 %81,79 %

    Aktieninformationen in AUD

    20192020202120222023e
    Aktien im Umlauf in Mio.320,06259,80353,88665,59681,68


    Aktionärsstruktur

    Profil

    Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. The company was incorporated in 1994 and is based in Mt Waverley, Australia.

    Kennzahlen und Daten von

    Paragon Care Kontakt

    AdressePIMCO Investments LLC distributor
    Telefon888-877-4626
    Internethttps://www.paragoncare.com.au